Key immune regulators in retinal ischemia-reperfusion injury via RNA sequencing
In the acute phase of RIRI, <i>Irf7</i> and <i>Tap1</i> may be the potential therapeutic targets to reduce inflammation and promote neurological function recovery.
Authors
- Xuxiang Zhang (ORCID: https://orcid.org/0000-0002-2833-0656)
- Heng Zhao (ORCID: https://orcid.org/0000-0001-6549-4644)
- Changhong Ren (ORCID: https://orcid.org/0000-0002-4230-784X)
- Shan He (ORCID: https://orcid.org/0000-0003-4032-1856)
- Tingting Meng (ORCID: https://orcid.org/0000-0002-1072-8666)
Institutions
- Capital Medical University (CN)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.18240/ijo.2025.07.06
- Citations
- 2
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- National Natural Science Foundation of China